DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
1-Year Est. Return 0.48%
This Quarter Est. Return
1 Year Est. Return
-0.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$10.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
111
New
Increased
Reduced
Closed

Top Buys

1
+$2.83M
2
+$2.52M
3
+$2.08M
4
IMMU
Immunomedics Inc
IMMU
+$1.89M
5
SYRE icon
Spyre Therapeutics
SYRE
+$1.7M

Top Sells

1
+$2.49M
2
+$2.21M
3
+$1.89M
4
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$1.37M
5
CYAD
Celyad Oncology SA American Depositary Shares
CYAD
+$1.32M

Sector Composition

1 Healthcare 71.01%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$579K 0.46%
26,690
+11,000
52
$551K 0.44%
+100,000
53
$549K 0.44%
53
54
$525K 0.42%
10,000
-36,010
55
$519K 0.41%
926
56
$446K 0.35%
+5,185
57
$444K 0.35%
14,060
58
$429K 0.34%
7,273
59
$423K 0.34%
1,825
60
$361K 0.29%
38,873
61
$360K 0.29%
2,792
+2,164
62
$358K 0.28%
119,300
-1,300
63
$339K 0.27%
352,882
64
$262K 0.21%
30,000
-110,265
65
$261K 0.21%
75,000
-40,230
66
$252K 0.2%
+140,275
67
$249K 0.2%
+25,907
68
$234K 0.19%
14,421
+13,219
69
$232K 0.18%
2,016
70
$205K 0.16%
+10,100
71
$204K 0.16%
+280
72
$204K 0.16%
2
73
$203K 0.16%
24,955
-63,145
74
$185K 0.15%
24,700
-41,000
75
$183K 0.15%
+1,563
1 2
3
4 5